FDA 483 - POINT Biopharma USA Inc. - June 07, 2024
FDA 483 for POINT Biopharma USA Inc. on June 07, 2024. Product: drugs. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for POINT Biopharma USA Inc. on June 07, 2024. Product: drugs. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Company
POINT Biopharma USA Inc.Inspection Date
June 7, 2024
Product Type
drugs
ID: 530b5998-d13e-4471-9be4-0fce34b92ddf
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox